Cars.com
CARS
Hutchmed (China)
HCM
Collegium Pharmaceutical
COLL
Teradata Corp
TDC
Workday
WDAY
US Stock MarketDetailed Quotes
NUWE Nuwellis
- 1.1700
- -0.0900-7.14%
Trading Mar 11 11:37 ET
5.12MMarket Cap-0.02P/E (TTM)
1.2700High1.1100Low129.74KVolume1.2600Open1.2600Pre Close153.95KTurnover2.97%Turnover Ratio0.00P/E (Static)4.37MShares16.625052wk High1.61P/B5.12MFloat Cap0.923752wk Low--Dividend TTM4.37MShs Float6085800000.0000Historical High--Div YieldTTM12.70%Amplitude0.9230Historical Low1.1860Avg Price1Lot Size
About Nuwellis Company
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
Company Profile
SymbolNUWE
Company NameNuwellis
Listing DateFeb 16, 2012
Founded1999
CEOMr. John L. Erb
MarketNASDAQ
Employees59
Fiscal Year Ends12-31
Address12988 Valley View Road
CityEden Prairie
ProvinceMinnesota
CountryUnited States of America
Zip Code55344
Phone1-952-345-4200
Company Executives
- Name
- Position
- Salary
- John L. Erb
- Chairman of the Board, Interim Chief Executive Officer and President
- 65.86K
- Robert Benjamin Scott
- Chief Financial Officer and Principal Accounting Officer
- 291.41K
- Neil P. Ayotte, Esq.
- Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
- 406.49K
- Michael McCormick
- Lead Independent Director
- 25.66K
- Dr. Archelle Georgiou, M.D.
- Independent Director
- --
- Gregory D. Waller
- Independent Director
- 68.86K
- David Alan McDonald
- Independent Director
- --
- Dr. Maria Rosa Costanzo, M.D.
- Independent Director
- 53.79K